Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 231-599-9 | CAS number: 7647-15-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Direct observations: clinical cases, poisoning incidents and other
Administrative data
- Endpoint:
- direct observations: clinical cases, poisoning incidents and other
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
Data source
Reference
- Reference Type:
- publication
- Title:
- Neonatal hypotonia secondary to transplacental bromism
- Author:
- Mangurten H.H. and Ban R.
- Year:
- 1 974
- Bibliographic source:
- The Journal of Pediatrics, Vol. 85, No. 3, pp. 426-428.
Materials and methods
- Study type:
- clinical case study
Test material
- Reference substance name:
- Liquid bromide mixture
- IUPAC Name:
- Liquid bromide mixture
- Details on test material:
- Mother ingested a liquid bromide mixture which contained 72 g ammonium bromide and 72 g potassium bromide per pint which is stated as being 0.3 g total bromide per mL.
This dose calculation may be incorrect as only by including the ammonium and potassium cations can the dose ingested be calculated to be 0.3 g/mL:
72 g/pt (NH4Br) + 72 g/pt (KBr) = 144 g/pt (total bromide salts)
144 g/pt ÷ 473 mL/pt (US) = 0.30 g/mL.
Using molecular weights, the following calculation may be made:
72 g NH4Br (MW = 97.9 g/mol) is equivalent to 58.7 g Br-.
72 g KBr (MW = 118.9 g/mol) is equivalent to 48.4 g Br-.
72 g/pt (NH4Br) + 72 g/pt (KBr) = 107.1 g(Br-)/pt (i.e. total bromide).
107.1 g(Br-)/pt ÷ 473 mL/pt (US) = 0.23 g(Br-)/mL.
Thus, the true dosage of bromide ingested may be lower than that indicated in the published article.
Constituent 1
Results and discussion
- Clinical signs:
- A pregnant mother was prescribed bromide-containing drugs (0.3 g total bromide per mL) for psychiatric treatment and took them (6 g/day) daily for 4 days until the day prior to delivery. The infant was born by caesarean section after 37 weeks gestation and described as large, puffy and quiet but in no distress. Neurological examination revealed an infant with a weak, high pitched cry, poor sucking and partial Moro reflex and diminished tone; deep tendon reflexes were absent. After exposure in the womb of up to 5 days prior to birth, the infant was born exhibiting signs of hypotonia and neurological depression. Maternal diabetes was suspected but serial determinations of concentrations of blood glucose, calcium and magnesium were all within normal limits. The serum bromide levels, first determined on the fifth day, were: 200 mg/100 mL (infant) and 310 mg/100 mL (mother) Urinary concentration: 166 mg/100 mL (infant - by this time the infant was more alert and was taking all feedings by nipple) Serial determinations of serum bromide concentrations revealed significant decrease over subsequent days. No treatment for bromide was administered as the discovery of high bromide levels was preceded by signs of improvement in the infant's condition. The patient was discharged after 15 days and by 5 months showed no residual manifestations of bromism. The serum bromide level was found to be 23 mg/100 mL at 69 days of age confirming the known slow clearance and increased renal tubular reabsorption of this ion.
Applicant's summary and conclusion
- Conclusions:
- Bromism intoxication shows signs compatible with a variety of causes, e.g. hypotonia and neurologic depression. In the case presented, once dosing had ceased the patient showed a steady improvement in general condition with no specific treatment from bromism. The serum bromide level found at 69 days of age confirms the known slow clearance and increased renal tubular reabsorption of this ion.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.